Contrasting Aegon NV (AEG) and Its Peers

Aegon NV (NYSE: AEG) is one of 29 public companies in the “Life & Health Insurance” industry, but how does it weigh in compared to its rivals? We will compare Aegon NV to related companies based on the strength of its earnings, institutional ownership, profitability, dividends, valuation, risk and analyst recommendations.

Earnings & Valuation

This table compares Aegon NV and its rivals top-line revenue, earnings per share and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Aegon NV $63.92 billion $3.21 billion 6.22
Aegon NV Competitors $28.59 billion $2.35 billion 53.79

Aegon NV has higher revenue and earnings than its rivals. Aegon NV is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Institutional & Insider Ownership

10.6% of Aegon NV shares are held by institutional investors. Comparatively, 68.4% of shares of all “Life & Health Insurance” companies are held by institutional investors. 9.6% of shares of all “Life & Health Insurance” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Aegon NV and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Aegon NV 5.18% 6.73% 0.40%
Aegon NV Competitors 5.21% 1.96% 1.96%

Risk and Volatility

Aegon NV has a beta of 1.35, suggesting that its share price is 35% more volatile than the S&P 500. Comparatively, Aegon NV’s rivals have a beta of 1.29, suggesting that their average share price is 29% more volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and target prices for Aegon NV and its rivals, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aegon NV 0 5 1 0 2.17
Aegon NV Competitors 232 1115 1671 80 2.52

Aegon NV currently has a consensus target price of $4.80, suggesting a potential downside of 15.19%. As a group, “Life & Health Insurance” companies have a potential upside of 7.74%. Given Aegon NV’s rivals stronger consensus rating and higher probable upside, analysts plainly believe Aegon NV has less favorable growth aspects than its rivals.

Dividends

Aegon NV pays an annual dividend of $0.25 per share and has a dividend yield of 4.4%. Aegon NV pays out 27.5% of its earnings in the form of a dividend. As a group, “Life & Health Insurance” companies pay a dividend yield of 2.2% and pay out 35.9% of their earnings in the form of a dividend. Aegon NV is clearly a better dividend stock than its rivals, given its higher yield and lower payout ratio.

Summary

Aegon NV rivals beat Aegon NV on 9 of the 15 factors compared.

About Aegon NV

Aegon N.V. (Aegon) is an international life insurance, pensions and asset management company. The Company’s segments include the Americas, which includes the United States, Mexico and Brazil; the Netherlands; the United Kingdom; Central & Eastern Europe; Spain & Portugal; Asia, and Aegon Asset Management. It offers protection against mortality, morbidity and longevity risks, including traditional and universal life. It offers products with mortality, morbidity, and longevity risks, including traditional and universal life; mortgages; annuity products, and banking products. It offers individual protection products, such as annuities, term insurance, income protection and international/offshore bonds. It has activities in the Czech Republic, Hungary, Poland, Romania, Slovakia and Turkey. It offers life insurance marketed to high-net-worth individuals in Hong Kong and Singapore. It also offers investment products covering third-party customers, insurance-linked solutions.

Receive News & Ratings for Aegon NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aegon NV and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply